#glucagonlikepeptide1 — Public Fediverse posts

https://www.europesays.com/uk/1237165/ Tirzepatide cuts fat mass by 35% while preserving skeletal muscle #Agonist #diabetes #diet #Dyslipidemia #fasting #Glucagon #GlucagonLikePeptide1 #Glucose #Health #Insulin #muscle #Obesity #ObstructiveSleepApnea #PhysicalActivity #prediabetes #PublicHealth #Receptor #Sleep #SleepApnea #Therapy #UK #UnitedKingdom #WeightLoss

https://www.europesays.com/ie/692629/ GLP-1 drugs and SGLT-2 inhibitors linked to slower kidney decline #Albuminuria #Chronic #ChronicKidneyDisease #diabetes #Drugs #Éire #Glucagon #GlucagonLikePeptide1 #Glucose #Health #IE #Ireland #Kidney #KidneyDisease #Protein #Receptor #Research #Type2Diabetes

https://www.europesays.com/ie/689121/ Tirzepatide vs semaglutide for asthma: the difference was smaller than researchers expected #Agonist #AirwayInflammation #allergy #Asthma #Chronic #Corticosteroid #diabetes #Éire #ElectronicHealthRecord #Glucagon #GlucagonLikePeptide1 #Glucose #HbA1c #Health #Healthcare #IE #inflammation #Ireland #Obesity #Prednisone #Receptor #semaglutide #Type2Diabetes

https://www.europesays.com/ie/677097/ GLP-1 drugs appear psychiatrically safe, but one finding still raises questions #Antidepressant #anxiety #Brain #Depression #DepressiveDisorder #diabetes #DiabetesMellitus #Diagnostic #Drugs #Éire #food #Glucagon #GlucagonLikePeptide1 #Glucose #Health #IE #Ireland #MajorDepressiveDisorder #Medication #MentalHealth #Obesity #Receptor #Research #semaglutide #Type2Diabetes

https://www.europesays.com/uk/1191666/ GLP-1 drugs appear psychiatrically safe, but one finding still raises questions #antidepressant #anxiety #brain #Depression #DepressiveDisorder #diabetes #DiabetesMellitus #Diagnostic #Drugs #Food #Glucagon #GlucagonLikePeptide1 #Glucose #Health #MajorDepressiveDisorder #Medication #MentalHealth #Obesity #Receptor #Research #Semaglutide #Type2Diabetes #UK #UnitedKingdom

https://www.europesays.com/ie/631012/ Semaglutide slows blood protein signature linked to future dementia risk #Agonist #blood #Brain #Cardiometabolic #CardiovascularDisease #CerebrovascularDisease #dementia #diabetes #Éire #Glucagon #GlucagonLikePeptide1 #Health #IE #Ireland #MachineLearning #Obesity #Placebo #Protein #Proteomics #Receptor #semaglutide #Vascular

https://www.europesays.com/ie/621130/ Mouse study shows how liraglutide briefly rewires gut bacterial communities #bacteria #Bacterial #Bile #Carbohydrate #Cardiometabolic #diet #DNA #Éire #food #Glucagon #GlucagonLikePeptide1 #Health #IE #Ireland #Microbiology #Microbiome #Obesity #Protein #Receptor #Research

https://www.europesays.com/uk/1130908/ GLP-1s not a ‘lifestyle product’ – The Star #DrugInducedPancreatitis #GlucagonLikePeptide1 #Health #InjectableMedicines #MedicalSupervision #Medication #Obesity #PublicHealth #ResponsibleUse #SafetyAdvisory #Type2Diabetes #UK #UnitedKingdom #WeightManagement

https://www.europesays.com/ie/601598/ Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits #Alcohol #diabetes #Éire #ElectronicHealthRecord #Glucagon #GlucagonLikePeptide1 #Health #HealthCare #Healthcare #hospital #IE #Ireland #Obesity #Receptor #Research #semaglutide #Type2Diabetes

https://www.europesays.com/uk/1090003/ Semaglutide dose may matter more than weight loss for heart health #Blood #BloodPressure #Cardiometabolic #CardiovascularDisease #Glucagon #GlucagonLikePeptide1 #Glucose #Health #heart #mortality #Obesity #Receptor #Semaglutide #UK #UnitedKingdom #WeightLoss

https://www.europesays.com/ie/584916/ Semaglutide dose may matter more than weight loss for heart health #blood #BloodPressure #Cardiometabolic #CardiovascularDisease #Éire #Glucagon #GlucagonLikePeptide1 #Glucose #Health #Heart #IE #Ireland #Mortality #Obesity #Receptor #semaglutide #WeightLoss

https://www.europesays.com/ie/582786/ Gut microbiota may shape eating behavior and guide new obesity treatments #appetite #Bacterial #blood #Brain #diet #Dysbiosis #EatingDisorder #Éire #food #Ghrelin #Glucagon #GlucagonLikePeptide1 #GutBrainAxis #IE #inflammation #Ireland #Leptin #MealTiming #Metabolites #Obesity #Pharmacology #prebiotics #Probiotics #Stress #Technology

GLP-1 medications may improve long-term health for people with peripheral artery disease https://www.byteseu.com/2156474/ #Agonist #amputations #Blood #BloodSugar #BloodVessel #cardiology #Chronic #ct #diabetes #GLP1 #Glucagon #GlucagonLikePeptide1 #Health #Heart #HeartAttack #Inflammation #InterventionalCardiology #Kidney #Medicine #metformin #Obesity #PeripheralArteryDisease #Receptor #Research #stroke #Type2Diabetes #WeightLoss

https://www.europesays.com/ie/527489/ GLP-1 medicines may cut clot-related risks in chronically inflamed patients #Agonist #Aids #AutoimmuneDisease #Éire #Glucagon #GlucagonLikePeptide1 #Health #Heart #IE #Ireland #Mortality #Obesity #PublicHealth #Receptor #Stroke #therapy

GLP-1 users say the drugs quiet food noise but do not replace lifestyle change

Interviews with patients across 15 US states revea…
#dining #cooking #diet #food #Food #cardiovasculardisease #chronic #Diabetes #drugs #Efficacy #Glucagon #glucagonlikepeptide1 #Healthcare #metabolism #nausea #obesity #receptor #Research #sleep #stomach #type2diabetes #weightloss #WeightManagement
https://www.diningandcooking.com/2676729/glp-1-users-say-the-drugs-quiet-food-noise-but-do-not-replace-lifestyle-change/

https://www.europesays.com/ie/473866/ People judge GLP-1 users more harshly than dieters #Agonist #diet #Drugs #Éire #Exercise #Glucagon #GlucagonLikePeptide1 #Health #Healthcare #IE #Ireland #Medication #MentalHealth #Obesity #Receptor #Research #semaglutide #Traction #WeightLoss

https://www.europesays.com/uk/914586/ People judge weight loss more harshly when GLP-1 drugs are involved, study finds #diet #Drugs #exercise #Glucagon #GlucagonLikePeptide1 #Health #Medication #Obesity #Receptor #Research #UK #UnitedKingdom #WeightLoss

https://www.europesays.com/ie/450964/ People judge weight loss more harshly when GLP-1 drugs are involved, study finds #diet #Drugs #Éire #Exercise #Glucagon #GlucagonLikePeptide1 #Health #IE #Ireland #Obesity #Receptor #Research #WeightLoss

https://www.europesays.com/ie/389218/ Patients who stop GLP-1 drugs often restart or try alternatives #diabetes #DiabetesMellitus #Drugs #Éire #FattyLiver #Glucagon #GlucagonLikePeptide1 #Glucose #Health #Healthcare #IE #Ireland #Liver #Metabolism #Obesity #ObstructiveSleepApnea #Receptor #semaglutide #Sleep #SleepApnea #Type2Diabetes #WeightLoss

https://www.europesays.com/ie/375258/ Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit #Addiction #Alcohol #Brain #Cannabis #diabetes #Drugs #Éire #Glucagon #GlucagonLikePeptide1 #Glucose #Health #Healthcare #IE #Ireland #Mortality #Nicotine #Overdose #pharmacy #Preclinical #Receptor #Research #Type2Diabetes

https://www.europesays.com/ie/372251/ Engineered lettuce may turn injectable GLP-1 therapies into oral pills #appetite #Biotechnology #blood #BloodSugar #Chloroplasts #diabetes #Drugs #Éire #Exenatide #Fasting #Genome #Glucagon #GlucagonLikePeptide1 #Health #Hormone #IE #Insulin #Ireland #Manufacturing #medicine #Obesity #oral #peptides #Receptor #Research #Stomach #Type2Diabetes #WeightManagement

https://www.europesays.com/ie/354769/ Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity #Agonist #Drugs #Efficacy #Éire #Glucagon #GlucagonLikePeptide1 #HbA1c #Hormone #IE #Ireland #Obesity #Placebo #Receptor #Technology #WeightLoss

https://www.europesays.com/ie/335256/ Users prioritize weight loss despite side effects #Agonist #BariatricSurgery #blood #cancer #CardiovascularDisease #Chronic #Constipation #diabetes #Drugs #Efficacy #Éire #Glucagon #GlucagonLikePeptide1 #Glucose #Health #IE #Internet #Ireland #MetabolicDisease #Mortality #Nausea #Obesity #PhysicalActivity #Receptor #Research #semaglutide #Surgery #Type2Diabetes #Vomiting #WeightLoss #WeightManagement

https://www.europesays.com/ie/303898/ Improving survival in people with severe psychiatric disorders #Agonist #BipolarDisorder #Cardiometabolic #CardiovascularDisease #Chronic #ChronicKidneyDisease #DepressiveDisorder #diabetes #Disability #Drugs #Éire #Exenatide #food #Glucagon #GlucagonLikePeptide1 #Health #IE #Ireland #Kidney #KidneyDisease #lithium #MajorDepressiveDisorder #MetabolicDisease #Mortality #Obesity #oral #Receptor #RenalDisease #Schizophrenia #Type2Diabetes

https://www.europesays.com/ie/214425/ Diabetes drugs linked to slower frailty progression in older adults #Aging #blood #BloodSugar #diabetes #Disability #Drugs #Éire #fatigue #Glucagon #GlucagonLikePeptide1 #Glucose #Health #Heart #IE #Ireland #Receptor #Research #semaglutide #Type2Diabetes

https://www.europesays.com/ie/211267/ WHO releases first guideline on the use of GLP-1 therapies for treating obesity #Chronic #ChronicDisease #diabetes #Efficacy #Éire #GlobalHealth #Glucagon #GlucagonLikePeptide1 #Health #IE #Ireland #Obesity #PhysicalActivity #Type2Diabetes

https://www.europesays.com/ie/186314/ Tirzepatide may only temporarily suppress brain activity involved in “food noise” #Agonist #BingeEatingDisorder #Brain #BrainSurgery #CT #diabetes #Drugs #EatingDisorder #Éire #food #Frequency #Glucagon #GlucagonLikePeptide1 #Glucose #Health #hospital #Hypothalamus #IE #Ireland #medicine #Neurosurgery #Obesity #Receptor #Research #Surgery #therapy #Type2Diabetes #WeightLoss

https://www.europesays.com/ie/152671/ WHO reviews highlight limited long-term data on GLP-1 drug safety #blood #BloodSugar #diabetes #diet #digestion #Drugs #Éire #Glucagon #GlucagonLikePeptide1 #Health #Heart #Hormone #IE #Ireland #Kidney #KidneyDisease #Obesity #Placebo #Receptor #Research #semaglutide #Type2Diabetes #WeightLoss #WeightManagement

https://www.europesays.com/ie/152401/ Diabetes remission possible with GLP-1 drugs, Italian study confirms #Agonist #blood #BloodPressure #diabetes #Drugs #Éire #Exenatide #Frequency #Glucagon #GlucagonLikePeptide1 #Glycemia #HbA1c #Health #IE #Insulin #Ireland #Pandemic #Receptor #semaglutide #Type2Diabetes #WeightLoss

Diabetes drugs may boost brain health but experts warn of risks https://www.byteseu.com/753882/ #Addiction #Anxiety #Brain #CognitiveFunction #dementia #depression #diabetes #Drugs #GLP1 #Glucagon #GlucagonLikePeptide1 #Health #Inflammation #Insulin #MentalHealth #Metabolism #Obesity #Preclinical #Receptor #Research #Schizophrenia #stress

Novo Nordisk confirms huge increase in sales despite supply constraints https://www.euractiv.com/section/health-consumers/news/novo-nordisk-confirms-huge-increase-in-sales-despite-supply-constraints/?utm_source=dlvr.it&utm_medium=mastodon #Copenhagen #Denmark #GLP1 #glucagonlikepeptide1 #novonordisk